BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9268733)

  • 1. Sodium butyrate induces NIH3T3 cells to senescence-like state and enhances promoter activity of p21WAF/CIP1 in p53-independent manner.
    Xiao H; Hasegawa T; Miyaishi O; Ohkusu K; Isobe Ki
    Biochem Biophys Res Commun; 1997 Aug; 237(2):457-60. PubMed ID: 9268733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Butyrate activates the WAF1/Cip1 gene promoter through Sp1 sites in a p53-negative human colon cancer cell line.
    Nakano K; Mizuno T; Sowa Y; Orita T; Yoshino T; Okuyama Y; Fujita T; Ohtani-Fujita N; Matsukawa Y; Tokino T; Yamagishi H; Oka T; Nomura H; Sakai T
    J Biol Chem; 1997 Aug; 272(35):22199-206. PubMed ID: 9268365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sodium butyrate inhibits cell growth and stimulates p21WAF1/CIP1 protein in human colonic adenocarcinoma cells independently of p53 status.
    Kobayashi H; Tan EM; Fleming SE
    Nutr Cancer; 2003; 46(2):202-11. PubMed ID: 14690797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of p21 gene expression in Caco-2 cells treated with sodium butyrate using real-time reverse transcription-PCR (RT-PCR) assay.
    Orchel A; Molin I; Dzierzewicz Z; Latocha M; Weglarz L; Wilczok T
    Acta Pol Pharm; 2003; 60(2):103-5. PubMed ID: 13678314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senescence-like changes induced by expression of p21(waf1/Cip1) in NIH3T3 cell line.
    Chen X; Zhang W; Gao YF; Su XQ; Zhai ZH
    Cell Res; 2002 Sep; 12(3-4):229-33. PubMed ID: 12296382
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a novel calcitonin-response element in the promoter of the human p21WAF1/CIP1 gene.
    Evdokiou A; Raggatt LJ; Sakai T; Findlay DM
    J Mol Endocrinol; 2000 Oct; 25(2):195-206. PubMed ID: 11013346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p21WAF/CIP1/SDI1 is upregulated due to increased mRNA stability during hydroxyurea-induced senescence of human fibroblasts.
    Kim HS; Yeo EJ; Park SH; Park JI; Park SC; Shin JY; Kim MJ; Oh SJ; Won MH; Kang TC; Park JB; Kim J; Kim JI; Lee HY; Lee JY
    Mech Ageing Dev; 2005 Dec; 126(12):1255-61. PubMed ID: 16111738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Butyrate-induced G1 arrest results from p21-independent disruption of retinoblastoma protein-mediated signals.
    Vaziri C; Stice L; Faller DV
    Cell Growth Differ; 1998 Jun; 9(6):465-74. PubMed ID: 9663465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acetylation of histones associated with the p21WAF1/CIP1 gene by butyrate is not sufficient for p21WAF1/CIP1 gene transcription in human colorectal adenocarcinoma cells.
    Kobayashi H; Tan EM; Fleming SE
    Int J Cancer; 2004 Mar; 109(2):207-13. PubMed ID: 14750171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B virus-X protein upregulates the expression of p21waf1/cip1 and prolongs G1-->S transition via a p53-independent pathway in human hepatoma cells.
    Park US; Park SK; Lee YI; Park JG; Lee YI
    Oncogene; 2000 Jul; 19(30):3384-94. PubMed ID: 10918595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p21(WAF1) is required for butyrate-mediated growth inhibition of human colon cancer cells.
    Archer SY; Meng S; Shei A; Hodin RA
    Proc Natl Acad Sci U S A; 1998 Jun; 95(12):6791-6. PubMed ID: 9618491
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histone deacetylase inhibitors decrease proliferation and modulate cell cycle gene expression in normal mammary epithelial cells.
    Davis T; Kennedy C; Chiew YE; Clarke CL; deFazio A
    Clin Cancer Res; 2000 Nov; 6(11):4334-42. PubMed ID: 11106251
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p21 gene regulation during enterocyte differentiation.
    Archer SY; Johnson JJ; Kim HJ; Hodin RA
    J Surg Res; 2001 Jun; 98(1):4-8. PubMed ID: 11368530
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of a functional role for p21WAF1/CIP1 down-regulation in synergistic antileukemic interactions between the histone deacetylase inhibitor sodium butyrate and flavopiridol.
    Rosato RR; Almenara JA; Yu C; Grant S
    Mol Pharmacol; 2004 Mar; 65(3):571-81. PubMed ID: 14978235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites.
    Huang L; Sowa Y; Sakai T; Pardee AB
    Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sodium butyrate induces growth arrest and senescence-like phenotypes in gynecologic cancer cells.
    Terao Y; Nishida J; Horiuchi S; Rong F; Ueoka Y; Matsuda T; Kato H; Furugen Y; Yoshida K; Kato K; Wake N
    Int J Cancer; 2001 Oct; 94(2):257-67. PubMed ID: 11668507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The histone deacetylase inhibitor butyrate downregulates cyclin B1 gene expression via a p21/WAF-1-dependent mechanism in human colon cancer cells.
    Archer SY; Johnson J; Kim HJ; Ma Q; Mou H; Daesety V; Meng S; Hodin RA
    Am J Physiol Gastrointest Liver Physiol; 2005 Oct; 289(4):G696-703. PubMed ID: 16160080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UV radiation is a transcriptional inducer of p21(Cip1/Waf1) cyclin-kinase inhibitor in a p53-independent manner.
    Haapajärvi T; Kivinen L; Heiskanen A; des Bordes C; Datto MB; Wang XF; Laiho M
    Exp Cell Res; 1999 Apr; 248(1):272-9. PubMed ID: 10094833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T-cell leukemia virus type 1 Tax activates cyclin-dependent kinase inhibitor p21/Waf1/Cip1 expression through a p53-independent mechanism: Inhibition of cdk2.
    Chowdhury IH; Farhadi A; Wang XF; Robb ML; Birx DL; Kim JH
    Int J Cancer; 2003 Nov; 107(4):603-11. PubMed ID: 14520699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of butyrate-induced apoptosis in human hepatoma cell lines HCC-M and HCC-T having substantial Bcl-2 expression.
    Saito H; Ebinuma H; Takahashi M; Kaneko F; Wakabayashi K; Nakamura M; Ishii H
    Hepatology; 1998 May; 27(5):1233-40. PubMed ID: 9581676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.